Antigenic peptide–major histocompatibility complex class II complex (pMHC-II complex or pMHCII)

Antigenic peptide–major histocompatibility complex class II complex refers to a molecular structure formed when a processed peptide (usually 13–25 amino acids in length) binds within the groove of a major histocompatibility complex class II molecule, which itself is typically present on the surface of professional antigen-presenting cells such as dendritic cells, macrophages, and B cells[1][2][4]. The class II molecule is a heterodimer composed of α and β chains, both containing extracellular domains that together create an open-ended peptide-binding groove, distinguishing it from class I MHC proteins[1][4]. These complexes display peptide antigens on the cell surface for recognition by the T cell receptor (TCR) of CD4+ T lymphocytes, which is a fundamental process underlying adaptive immune activation, regulation of immune responses, and maintenance of self-tolerance[2][5][7]. The formation and stability of peptide–MHC II complexes are highly allele-specific and influenced by peptide sequence and affinity, and their presentation is centrally involved in immune surveillance but also contributes to the development of autoimmune and inflammatory diseases[1][6]. They are key therapeutic and diagnostic targets for modulation of immune responses in autoimmunity, infection, transplantation, and cancer immunotherapy[2][5].

Other names

peptide–MHC class II complexpMHCII complexMHC class II–peptide complexclass II MHC–peptide complexHLA class II–peptide complex (in humans)

Blockade or modulation of antigen presentation to CD4+ T cells Induction or suppression of immune tolerance Alteration of T cell activation thresholds by interfering with the T cell receptor–peptide:MHC II interaction